The contents of this section were published in 2003 as part of SEER's 30th Anniversary celebration.
"Today, SEER stands as the model and standard of excellence for cancer registries, both on a national and international scale. Despite the enormous challenges involved in monitoring cancer in the large, mobile, and diverse U.S. population, SEER has succeeded in building an extraordinary resource that has in so many ways galvanized epidemiologic research into the causes and control of cancer. Visionary in concept, SEER has earned its name with an unprecedented ability to identify emerging trends, geographic variation, ethnic disparities, and other patterns that have provided new directions for epidemiologic research in cancer etiology and control."
- Joseph F. Fraumeni, Jr., M.D., Director, Division of Cancer Epidemiology and Genetics, NCI
During its 30 year history, SEER has made many scientific contributions to epidemiologic research in the areas of cancer care and treatment, cancer screening, prevention, and risk, genetics, health disparities, health policy and economics, models and methods, and cancer reporting. These contributions are demonstrated through the number of landmark studies in surveillance, epidemiology, and end results.
Download the complete SEER Landmark Studies brochure (PDF, 264 KB) .
Index of Studies by Research Topic
Agricultural Health Study
Cancer and Steroid Hormone Study (CASH)
Cancer in Immigrants
Environmental Tobacco Smoke
Esophagus and Gastric Cardia
Lifetime Risk of Breast Cancer
Women's Interview Study of Health (WISH)
Models and Methods
The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.